IMMUNOLOGICAL MECHANISMS OF RESISTANCE TO CDK4/CDK6 INHIBITORS IN BREAST CANCER

被引:1
|
作者
Petroni, Giulia [1 ]
Gouin, Kenneth [2 ]
Martinez, Aitziber Buque [1 ]
Knott, Simon [2 ]
Formenti, Silvia [1 ]
Galluzzi, Lorenzo [1 ,3 ]
机构
[1] Weill Cornell Med Coll, Brooklyn, NY USA
[2] Cedars Sinai, Los Angeles, CA USA
[3] Weill Cornell Med, New York, NY USA
关键词
D O I
10.1136/jitc-2021-SITC2021.733
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
733
引用
收藏
页码:A763 / A763
页数:1
相关论文
共 50 条
  • [41] The role of CDK4/6 inhibitors in early breast cancer
    Gil-Gil, Miguel
    Alba, Emilio
    Gavila, Joaquin
    de la Haba-Rodriguez, Juan
    Ciruelos, Eva
    Tolosa, Pablo
    Candini, Daniele
    Llombart-Cussac, Antonio
    BREAST, 2021, 58 : 160 - 169
  • [42] CDK4/6 inhibitors in breast cancer: spotting the difference
    Jose Manuel Perez-Garcia
    Javier Cortes
    Antonio Llombart-Cussac
    Nature Medicine, 2021, 27 : 1868 - 1869
  • [43] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Kharenko, Olesya A.
    Patel, Reena G.
    Calosing, Cyrus
    van der Horst, Edward H.
    CANCER GENE THERAPY, 2022, 29 (06) : 859 - 869
  • [44] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Olesya A. Kharenko
    Reena G. Patel
    Cyrus Calosing
    Edward H. van der Horst
    Cancer Gene Therapy, 2022, 29 : 859 - 869
  • [45] Targeting CDK4 and CDK6: From Discovery to Therapy
    Sherr, Charles J.
    Beach, David
    Shapiro, Geoffrey I.
    CANCER DISCOVERY, 2016, 6 (04) : 353 - 367
  • [46] The identification of combinations for the CDK4 and CDK6 inhibitor, abemaciclib
    Gong Xueqian
    Chio, Li-Chun
    Webster, Yue
    Lallena, Maria Jose
    Boehnke, Karsten
    Torres, Raquel
    Iversen, Phil
    De Dios, Alfonso
    Smith, Ian
    Reinhard, Christoph
    Peng, Sheng-Bin
    Dempsey, Jack
    Burke, Teresa
    Chen, Shih-Hsun
    Stewart, Trent
    Beckmann, Richard
    Wu, Wenjuan
    Buchanan, Sean G.
    MOLECULAR CANCER RESEARCH, 2016, 14
  • [47] Mechanisms of therapeutic CDK4/6 inhibition in breast cancer
    Scott, Susan Combs
    Lee, Sarah S.
    Abraham, Jame
    SEMINARS IN ONCOLOGY, 2017, 44 (06) : 385 - 394
  • [48] Resistance mechanisms to CDK4/6 Inhibition
    O'Leary, Ben
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 589 - 589
  • [49] Mechanisms of resistance to CDK4/6 inhibitors and new therapeutic approaches
    Chandarlapaty, S.
    CANCER RESEARCH, 2020, 80 (04)
  • [50] Combined inhibition of CDK2 and CDK4/6 overcomes acquired resistance to CDK4/6 inhibitors in breast cancer via RB-independent pathway
    Pandey, Kamal
    CANCER RESEARCH, 2020, 80 (16)